Hepatic abscess caused by Aspergillus fumigatus infection following splenectomy and immunosuppressive therapy

Journal of the Formosan Medical Association

Volumn 102, Issue 7, 2003, Pages 501-505

  Lee, Teng Yu ^a   Yang, Sheng Shun ^a   Chen, Gran Hum ^a   Hwang, Wen Li ^a   Lin, Yu Hui ^a   Hwang, Jen I ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Aplastic anemia; Aspergillus fumigatus; Immunosuppression; Liver abscess; Splenectomy

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFTRIAXONE; CORTICOSTEROID; CYCLOSPORIN; FLUCONAZOLE; METHYLTESTOSTERONE; METRONIDAZOLE; PREDNISOLONE; THYMOCYTE ANTIBODY;

ABDOMEN; AGED; APLASTIC ANEMIA; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CULTURE TECHNIQUE; DEATH; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; ECHOGRAPHY; FEVER; HEPATOGRAPHY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER ABSCESS; LIVER BIOPSY; MALE; MORBIDITY; MORTALITY; MYCOSIS; NONHUMAN; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; SEPSIS; SPLENECTOMY;

AGED; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; FATAL OUTCOME; HUMANS; IMMUNOSUPPRESSION; LIVER ABSCESS; MALE; SPLENECTOMY;

EID: 0347627780     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Soriano V, Cobo J, Gutierrez M, et al: Aspergillus hepatosplenic abscesses and chylous ascites: Successful treatment with fluconazole. Eur J Med 1992;1:253-4.
2. D'Silva H, Burke JF Jr, Cho SY: Disseminated aspergillosis in a presumably immunocompetent host. JAMA 1982;248:1495-7.
3. Lipsett PA, Huang CJ, Lillemoe KD, et al: Fungal hepatic abscess: characterization and management. J Gastrointest Surg 1997;1:78-84
4. Ochsner A, DeBakey M, Murray S: Pyogenic abscess of the liver. II. An analysis of forty-seven cases with review of the literature. Am J Surg 1938;40:292-319.
5. Srivasta ED, Mayberry JF: Pyogenic liver abscess: A review of etiology, diagnosis, and intervention. Dig Dis 1990;8:287.
6. Rocyey DC: Hepatobiliary infections. Current Opin Gastroenterol 2001;17:257.
7. Fraser DW, Ward JI, Ajello L, et al: Aspergillosis and other systemic mycoses: The growing problem. JAMA 1979;242:1631-5.
8. Marcus SG, Walsh TJ, Pizza PA, et al: Hepatic abscess in cancer patients. Characterization and management. Arch Surg 1993 128:1358-64.
9. Denning DW, Lee JY, Hostetler JS, et al: Mycoses Study Group multicenter trial of oral intraconazole therapy for invasive Aspergillosis. Am J Med 1994;97:135-144.
10. Denning DW: Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996;23:608-15.
11. Patterson TF, Kirkpatrick WR, White M, et al: Invasive aspergillosis: disease spectrum, treatment, practices, and outcomes. Medicine 2000;79:256-260.
12. Sung JL, Chuang CR, Yu JY: Clinical observation of liver abscess. J Formos Med Assoc 1962;61:545-64.
13. Lau YJ, Hu BS, Wu WL, et al: Identification of a major cluster of Klebsiella pneumoniae isolates from patients with liver abscess in Taiwan. J Clin Microbiol 2000;38:412-4.
14. Chen CY, Chen YC, Tang JL, et al: Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: Incidence, treatment and prognosis. Ann Hematol 2003;82:93-7.
15. Latge JP: Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12:310-50.
16. Chandrasekar PH, Cutright JL, Manavathu EK: Aspergillus: Rising frequency of Clinical isolation and continued susceptibility to antifungal agents, 1994-1999. Diagn Microbiol Infect Dis 2001; 41:211-4.
17. Barreda R, Ros PR: Diagnostic imaging of liver abscess. Crit Rev Diagn Imaging 1992;33:29-58.
18. Abraham OC, Manavathu EK, Cutright JL, et al: In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B. Diagn Microbiol Infect Dis 1999; 33:7-11
19. Solomkin JS, Simmons RL: Candida infection in surgical patients. World J Surg 1980;4:381-94.